From November 8, 2021 to December 31, 2021, the company has repurchased 1,581,300 shares, representing 2.58% for ¥4,760.13 million. With this, the company has completed the repurchase of 1,581,300 shares, representing 2.58% for ¥4,760.13 million under the buyback announced on November 8, 2021.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,638 JPY | -1.65% | -0.94% | -0.43% |
Apr. 08 | AstraZeneca hails neurological data for Ultomiris, Soliris | AN |
Apr. 08 | AstraZeneca's, Daiichi's Enhertu receives US FDA approval | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.43% | 2.36B | |
+13.93% | 8.46B | |
-23.96% | 718M | |
+10.12% | 695M | |
+31.78% | 367M | |
+3.44% | 342M | |
+5.37% | 340M | |
+16.47% | 188M | |
+28.08% | 101M | |
-28.70% | 62.86M |
- Stock Market
- Equities
- 6417 Stock
- News Sankyo Co., Ltd.
- Tranche Update on Sankyo Co., Ltd.'s Equity Buyback Plan announced on November 8, 2021.